文献速递肺外科

淋巴结清扫在部分实性肺腺癌中的意义:倾向性评分匹配分析

Significance of Lymphadenectomy in Part-Solid Lung Adenocarcinoma: Propensity Score Matched Analysis.
PubMed 文献 · Ann Thorac Surg · 2018-05-28

本研究回顾了462例接受肺叶或肺段切除加淋巴结清扫的临床I期影像学部分实性肺腺癌患者,比较系统/肺叶特异性纵隔淋巴结清扫(m-LND)与仅肺门淋巴结清扫(h-LND)的预后差异。倾向性评分匹配分析显示,两组总生存无显著差异,淋巴结清扫范围与生存结局无关,即使对实性为主病灶亦无影响。

要点

  • 部分实性肺腺癌淋巴结转移率低,仅16例(实性为主病灶中占4.9%)。
  • m-LND组314例(68%),h-LND组148例(32%),5年OS分别为94.2%和92.8%(p=0.585)。
  • 倾向性评分匹配后(92对),m-LND与h-LND的5年OS分别为94.0%和93.2%(p=0.845)。

核心结论

  • 淋巴结清扫范围与部分实性肺腺癌的生存结局无关。
  • 即使对实性为主病灶,倾向性评分分析显示清扫范围对预后亦无影响,可基于术前癌胚抗原或最大标准化摄取值等变量选择性省略淋巴结清扫。

研究设计与样本

  • 回顾性分析462例临床I期影像学部分实性肺腺癌患者,均接受肺叶或肺段切除加淋巴结清扫。
  • 所有患者评估实性成分肿瘤比,淋巴结清扫范围分为系统/肺叶特异性纵隔淋巴结清扫(m-LND)和仅肺门淋巴结清扫(h-LND)。
  • 采用倾向性评分匹配的多变量分析评估淋巴结清扫的预后意义,生存用Kaplan-Meier法计算并以log rank检验比较。

主要发现

  • m-LND组314例(68%),h-LND组148例(32%)。
  • 总生存(OS)在m-LND与h-LND间无显著差异(5年OS 94.2% vs 92.8%,p=0.585),92对匹配后亦无显著差异(5年OS 94.0% vs 93.2%,p=0.845)。
  • Cox比例风险模型显示最大标准化摄取值是独立显著的肿瘤预后因素(p=0.003),而淋巴结清扫范围不是(p=0.997)。
  • 16例发现淋巴结受累,且仅见于实性为主病灶(即0.5<实性成分肿瘤比≤1.0;占4.9%)。
  • 实性为主病灶中,多变量分析显示癌胚抗原和最大标准化摄取值是淋巴结转移的显著预测因素(p=0.001,p=0.002)。

关键数值与推荐

  • 部分实性肺腺癌实性为主病灶(0.5<实性成分肿瘤比≤1.0)中淋巴结受累率为4.9%。
  • 实性为主病灶中,癌胚抗原和最大标准化摄取值是淋巴结转移的显著预测因素(p=0.001,p=0.002)。

临床怎么用

  • 作者认为,淋巴结清扫范围与部分实性肺腺癌生存无关,可基于术前癌胚抗原或最大标准化摄取值等变量选择性省略淋巴结清扫。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: It is evident that the frequency of nodal metastasis in part-solid lung adenocarcinoma is significantly low. For those cases, the prognostic impact of the lymph node dissection (LND) is highly controversial. METHODS: We reviewed 462 clinical stage I radiologic part-solid lung adenocarcinoma patients who underwent lobectomy or segmentectomy with lymphadenectomy. Consolidation tumor ratio was evaluated for all patients. Extent of LND was classified into systematic/lobe-specific mediastinal LND (m-LND) and hilar LND only (h-LND). Prognostic significance of LND was assessed by a multivariable analysis using propensity score matching. Survival was calculated by the Kaplan-Meier method using the log rank test. RESULTS: The m-LND was performed in 314 patients (68%), and h-LND in 148 (32%). Overall survival (OS) was not significantly different between m-LND and h-LND (5-year OS, 94.2% versus 92.8%, p = 0.585), as shown in 92 matched pairs (5-year OS, 94.0% versus 93.2%, p = 0.845). Cox proportional hazards model revealed maximum standardized uptake value as an independently significant oncologic prognosticator (p = 0.003), but extent of LND was not (p = 0.997). Nodal involvement was found in 16 patients, and was exclusive in solid-dominant lesions (ie, 0.5 less than consolidation tumor ratio of 1.0 or less; 4.9%). Multivariable analysis revealed carcinoembryonic antigen and maximum standardized uptake value as significant predictors of nodal metastasis among solid-dominant lesions (0.001, 0.002). For 329 solid-dominant lesions (71%), however, survival was similar between m-LND and h-LND (5-year OS, 93.2% versus 87.1%, p = 0.097), and was proven in 58 matched pairs (5-year OS, 82.9% versus 82.9%, p = 0.822). CONCLUSIONS: Extent of LND was not associated with survival outcome of part-solid lung adenocarcinoma. Furthermore, it had no influence on the prognosis even for solid-dominant lesions by propensity score analysis, which could be selectively omitted based on both preoperative variables including carcinoembryonic antigen or maximum standardized uptake value.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Hattori A, Matsunaga T, Takamochi K, et al. Significance of Lymphadenectomy in Part-Solid Lung Adenocarcinoma: Propensity Score Matched Analysis. Ann Thorac Surg. 2018. PMID: 29852148. doi:10.1016/j.athoracsur.2018.04.069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。